Sanuwave Health Inc. (SNWV)
NASDAQ (NMS) NASDAQ (NMS) Primary Summary
Sanuwave Health Q1 Earnings Call Highlights
Sanuwave Health NASDAQ: SNWV reported record first-quarter revenue and rising consumables utilization, while management said the advanced wound care market began to recover after a difficult start to the year tied to changes in reimbursement for skin substitutes.
Sanuwave Health Inc. (SNWV) Reports Q1 Loss, Beats Revenue Estimates
Sanuwave Health Inc. (SNWV) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $0.66 per share a year ago.
Sanuwave Health Inc. (SNWV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Sanuwave Health (SNWV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sanuwave Health Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Joseph Castro Nuveen LLC | 13,136 | $368,901.87 | $99,176.8 | -$269,725.07 | -73.12% |
| PZ Paul Zavaliy Praetorian PR LLC | 350,000 | $9.51M | $2.36M | -$7.15M | -75.16% |
| HFT Hui Fai Tam Caitong International Asset Management Co. Ltd. | 3 | $52 | $20.28 | -$31.72 | -61% |
 Alexandra Stickelman Root Financial Partners, LLC | 7 | $121 | $46.34 | -$74.66 | -61.7% |
 James Luthardt KIRTLAND HILLS CAPITAL MANAGEMENT, LLC | 2,775 | $47,979.75 | $18,315 | -$29,664.75 | -61.83% |
Sanuwave Health Inc. (SNWV) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Sanuwave Health Inc. ever had a stock split?
Sanuwave Health Inc. Profile
| Health Care Technology Industry | Healthcare Sector | Morgan C. Frank CEO | NASDAQ (NMS) Exchange | 80303D305 CUSIP |
| US Country | 55 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
SANUWAVE Health, Inc. is at the forefront of the medical field with its innovative use of shock wave technology. This company is dedicated to the research, development, and commercialization of noninvasive, high-energy, and acoustic shock waves for regenerative medicine and various other applications both in the United States and internationally. Founded in 2004 and based in Eden Prairie, Minnesota, SANUWAVE aims to harness the power of these shockwaves to stimulate a biological response, encouraging the body to heal itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. By focusing on this niche, SANUWAVE Health, Inc. is leading the way in providing advanced solutions for regenerative healing and pain management.
Products and Services
- dermaPACE System
- orthoPACE System
- Profile
- UltraMIST
This system is designed to treat diabetic foot ulcers and other chronic wounds. It employs SANUWAVE's proprietary pulsed acoustic cellular expression technology to accelerate the healing process, improving the body's natural regeneration of skin and tissue through noninvasive means. This approach provides a revolutionary way to tackle difficult-to-heal wounds, offering hope and healing to patients suffering from these chronic conditions.
Targeted at treating tendinopathies, acute, and nonunion fractures, the orthoPACE system uses shock wave technology to stimulate the healing process. It is especially useful in the orthopedic field, where it aids in the recovery of musculoskeletal injuries by enhancing the body's repair mechanisms. This system is valuable for athletes and individuals suffering from various orthopedic conditions, offering a noninvasive alternative to traditional treatments.
Developed to cater to needs in sports medicine and physical therapy, the Profile system is SANUWAVE Health's answer to pain management. By leveraging shock wave technology, it provides a solution that not only manages pain but also promotes the healing of musculoskeletal injuries. This makes it an essential tool for therapists and sports medicine professionals seeking effective and noninvasive treatment options for their patients.
This device represents a non-contact and non-thermal ultrasound therapy solution aimed at treating diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds. UltraMIST stands out for providing a gentle yet effective treatment option that stimulates the body's natural healing processes without the need for invasive procedures. It is particularly beneficial for patients with wounds that are resistant to conventional therapies, offering a fresh approach to wound care and management.
